Strategic Alliance with Novaspire

We are pleased to announce that Abhinavayan Biotech and Novaspire Biosciences have signed a Memorandum of Understanding (MOU) to build integrated end-to-end discovery and development pathways across the life sciences sector.

This strategic collaboration significantly enhances our combined service portfolio, bringing together seasoned global experts with a strong track record in preclinical drug discovery and development innovation, global clinical execution, regulatory strategy, medical monitoring, and successful out licensing partnerships. Together, we aim to deliver integrated solutions that accelerate development timelines and create meaningful value for sponsors.

What this partnership enables:

• One-stop, integrated solutions: from early drug discovery to post-marketing surveillance

• Seamless project execution: enabled by shared expertise and streamlined, scalable frameworks

• Enhanced operational discipline: through aligned processes, governance, and quality systems

• Expanded global reach: leveraging international clinical, regulatory, and operational networks

• Value creation for stakeholders: through innovative, outcome driven development strategies

  
  

Leadership Perspectives:

“With deep experience in preclinical drug discovery and development, my focus has always been on translating scientific innovation into high impact therapies. This collaboration strengthens our ability to move promising assets efficiently from discovery toward patients, while creating real value across the product lifecycle.”

— Dr. Nagaraj Gowda,

Chairman & Managing Director, Abhinavayan Biotech

“Our strength lies in globally executed clinical programs grounded in regulatory rigor, strong clinical operations, and robust medical monitoring. Together with Abhinavayan, we are building an integrated framework that enables sponsors to advance programs with confidence, speed, and global consistency.”

— Dr. Sai Vijayadevan,

Chief Executive Officer, Novaspire Biosciences

By combining innovation led discovery with globally integrated clinical development and regulatory execution, this partnership is designed to deliver collaborations that are credible, agile, and strategically aligned with the evolving needs of the Pharmaceutical, Biotechnology, Nutraceutical, and Medical Device industries.

We look forward to shaping meaningful outcomes together and driving the next chapter of sustainable growth in the life sciences ecosystem.